Chip Stocks Jump Most Since 2015 After NXP Eases Demand Fear
(Bloomberg) -- Semiconductor stocks jumped Thursday after earnings results from NXP Semiconductors NV helped assuage fears about slumping chip demand.
The Philadelphia Semiconductor Index rose 4.6 percent in New York trading, the biggest gain since August 2015. The surge extended the index's three-day rally to 10 percent. Chip stocks, along with other technology stocks, were among the hardest hit last month as markets tumbled amid a spike in volatility. The group of 30 semiconductor-related stocks slumped 12 percent in October, its worst month since 2010.
“The absence of bad news is good news,” said Anand Srinivasan, a Bloomberg Intelligence senior analyst covering semiconductor companies. “Today looks like a relief rally.”
NXP, the biggest supplier of chips to the automotive industry, surged 12 percent after third-quarter revenue beat estimates and its sales forecast for the fourth quarter was roughly in-line.
“Results were very solid, especially given recent sector cyclical concerns,” Bernstein analyst Stacy Rasgon wrote in a research note. Other big semiconductor movers included Advanced Micro Devices Inc., which gained 11 percent, and ON Semiconductor Corp., which rose 8.2 percent.
To contact the reporter on this story: Jeran Wittenstein in San Francisco at jwittenstei1@bloomberg.net
To contact the editors responsible for this story: Catherine Larkin at clarkin4@bloomberg.net, Brad Olesen
©2018 Bloomberg L.P.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.